In a stunning move that signals growing institutional confidence in cryptocurrency, Nasdaq-listed biopharmaceutical company Enlivex has announced plans to purchase $212 million worth.
In a groundbreaking move that signals growing institutional crypto adoption, Nasdaq-listed Propanc Biopharma has secured up to $100 million specifically for cryptocurrency purchases..